Rodgers Brothers Inc. Abbott Laboratories Transaction History

Rodgers Brothers Inc.

$725 Million
Q3 2024

A detailed history of Rodgers Brothers Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Rodgers Brothers Inc. holds 144,398 shares of ABT stock, worth $16.7 Million. This represents 2.27% of its overall portfolio holdings.

Number of Shares

144,398

Previous 141,120 2.32%

Holding current value

$16.7 Million

Previous $14.7 Million 12.27%

% of portfolio

2.27%

Previous 2.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $328,029 - $387,230	3,278 Added 2.32%	144,398 $16.5 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $13,195 - $14,729	131 Added 0.09%	141,120 $14.7 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $964,871 - $1.07 Million	-8,810 Reduced 5.88%	140,989 $16 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $18,849 - $23,073	-209 Reduced 0.14%	149,799 $16.5 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $933,423 - $1.12 Million	9,771 Added 6.97%	150,008 $14.5 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $853,908 - $951,433	8,473 Added 6.43%	140,237 $15.3 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $154,976 - $182,416	1,600 Added 1.23%	131,764 $13.3 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $120,060 - $140,849	1,263 Added 0.98%	130,164 $14.3 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $1.11 Million - $1.28 Million	11,427 Added 9.73%	128,901 $12.5 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $15,310 - $18,505	150 Added 0.13%	117,474 $12.8 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $9,121 - $11,123	-80 Reduced 0.07%	117,324 $13.9 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $39,164 - $47,954	-339 Reduced 0.29%	117,404 $16.5 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $20,065 - $22,198	-172 Reduced 0.15%	117,743 $13.9 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $41,363 - $48,691	-391 Reduced 0.33%	117,915 $13.7 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $66,174 - $77,963	608 Added 0.52%	118,306 $14.2 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $109,095 - $118,882	-1,039 Reduced 0.88%	117,698 $12.9 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $68,455 - $83,133	-747 Reduced 0.63%	118,737 $12.9 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $51,148 - $65,464	-668 Reduced 0.56%	119,484 $10.9 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $29,713 - $43,449	-473 Reduced 0.39%	120,152 $9.48 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $21,119 - $23,510	269 Added 0.22%	120,625 $10.5 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $84,458 - $91,579	-1,032 Reduced 0.85%	120,356 $10.1 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $12,608 - $14,705	-173 Reduced 0.14%	121,388 $10.2 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $27,083 - $32,744	409 Added 0.34%	121,561 $9.72 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $41,565 - $47,087	634 Added 0.53%	121,152 $8.76 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $31,195 - $37,633	-513 Reduced 0.42%	120,518 $8.84 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $124,639 - $137,564	2,165 Added 1.82%	121,031 $7.38 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $56,044 - $63,365	996 Added 0.84%	118,866 $7.12 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $6,280 - $6,723	-117 Reduced 0.1%	117,870 $6.73 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $5.67 Million - $6.33 Million	117,987	117,987 $6.3 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rodgers Brothers Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rodgers Brothers Inc. with notifications on news.

Account

Rodgers Brothers Inc. Abbott Laboratories Transaction History